Aurinia presents AURORA pivotal trial subgroup analysis of voclosporin for lupus nephritis at the EULAR 2020 E-Congress.
Aurinia Pharmaceuticals Inc. announced that new subgroup analyses from the completed AURORA pivotal trial of voclosporin were presented at the European League Against Rheumatism (EULAR) 2020 E-Congress in… read more.